Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription 04.06.2018 1 Arch Virol 2 BMJ 1 Clin Infect Dis 1 Indian Pediatr 5 J Infect Dis 4 Lancet 3 MMWR Morb Mortal Wkly Rep 10 PLoS One 14 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Virol

1. MOZHGANI SH, Malekpour SA, Norouzi M, Ramezani F, et al
   Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
   Arch Virol. 2018 Feb 13. pii: 10.1007/s00705-018-3764.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

2. HAWKES N
   Journals retract four articles criticising vaccines by author who used a pseudonym.
   BMJ. 2018;361:k2394.
   PubMed     Text format    
   
   
3. WISE J
   WHO is "cautiously optimistic" about Ebola ring vaccination programme in DRC.
   BMJ. 2018;361:k2388.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

4. SORUP S, Jensen AKG, Aaby P, Benn CS, et al
   Revaccination with Measles-mumps-rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.
   Clin Infect Dis. 2018 May 26. pii: 5005938. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Indian Pediatr

5. DUTTA AK
   Hepatitis B Vaccination Strategies Using Combination Vaccines for Low Birthweight Infants.
   Indian Pediatr. 2018;55:379-380.
   PubMed     Text format    
   
   

   
   J Infect Dis

6. PAMNANI SJ, Sudenga SL, Rollison DE, Ingles DJ, et al
   Recurrence of Genital Infections with Nine HPV Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among Men in the HPV Infection in Men (HIM) Study.
   J Infect Dis. 2018 May 24. pii: 5002064. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
7. PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
   Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
   J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. CHAKRABORTY S, Randall A, Vickers TJ, Molina D, et al
   Human experimental challenge with enterotoxigenic Escherichia coli elicits immune responses to canonical and novel antigens relevant to vaccine development.
   J Infect Dis. 2018 May 24. pii: 5003007. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
9. KAINULAINEN MH, Spengler JR, Welch SR, Coleman-McCray JD, et al
   Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.
   J Infect Dis. 2018;217:1957-1966.
   PubMed     Text format     Abstract available
   
   
10. SWANSTROM JA, Henein S, Plante JA, Yount BL, et al
    Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.
    J Infect Dis. 2018;217:1932-1941.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

11. KELLY JD, Mukadi P, Dhillon RS
    Beyond vaccines: improving survival rates in the DRC Ebola outbreak.
    Lancet. 2018 May 25. pii: S0140-6736(18)31212.
    PubMed     Text format    
    
    
12. MACARTNEY K, Gershon AA
    Shingles vaccine after auto-HSCT decreases risk.
    Lancet. 2018;391:2082-2084.
    PubMed     Text format    
    
    
13. CORCORAN B, Clarke A, Barrett T
    Rapid response to HPV vaccination crisis in Ireland.
    Lancet. 2018;391:2103.
    PubMed     Text format    
    
    
14. WINSTON DJ, Mullane KM, Cornely OA, Boeckh MJ, et al
    Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2018;391:2116-2127.
    PubMed     Text format     Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

15. KHANAL S, Bahl S, Sharifuzzaman M, Dhongde D, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:602-606.
    PubMed     Text format     Abstract available
    
    
16. TIPPINS A, Murthy N, Meghani M, Solsman A, et al
    Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:579-584.
    PubMed     Text format     Abstract available
    
    
17. SHIMABUKURO TT, Miller ER, Strikas RA, Hibbs BF, et al
    Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine - United States, 2017-2018.
    MMWR Morb Mortal Wkly Rep. 2018;67:585-586.
    PubMed     Text format    
    
    

    
    PLoS One

18. 
    Correction: Development of experimental GBS vaccine for mucosal immunization.
    PLoS One. 2018;13:e0198577.
    PubMed     Text format     Abstract available
    
    
19. SELLENS E, Norris JM, Dhand NK, Heller J, et al
    Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.
    PLoS One. 2018;13:e0198421.
    PubMed     Text format     Abstract available
    
    
20. ILYINSKII PO, Kovalev GI, O'Neil CP, Roy CJ, et al
    Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
    PLoS One. 2018;13:e0197694.
    PubMed     Text format     Abstract available
    
    
21. SHENG X, Liu M, Liu H, Tang X, et al
    Identification of immunogenic proteins and evaluation of recombinant PDHA1 and GAPDH as potential vaccine candidates against Streptococcus iniae infection in flounder (Paralichthys olivaceus).
    PLoS One. 2018;13:e0195450.
    PubMed     Text format     Abstract available
    
    
22. CAYROU C, Akinduko AA, Mirkes EM, Lucidarme J, et al
    Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
    PLoS One. 2018;13:e0197186.
    PubMed     Text format     Abstract available
    
    
23. KOOIJMAN S, Brummelman J, van Els CACM, Marino F, et al
    Vaccine antigens modulate the innate response of monocytes to Al(OH)3.
    PLoS One. 2018;13:e0197885.
    PubMed     Text format     Abstract available
    
    
24. DE PASCALIS R, Hahn A, Brook HM, Ryden P, et al
    A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
    PLoS One. 2018;13:e0198140.
    PubMed     Text format     Abstract available
    
    
25. SOUTHERN J, Andrews N, Sandu P, Sheppard CL, et al
    Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
    PLoS One. 2018;13:e0195799.
    PubMed     Text format     Abstract available
    
    
26. KUCHENBECKER U, Chase D, Reichert A, Schiffner-Rohe J, et al
    Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
    PLoS One. 2018;13:e0197905.
    PubMed     Text format     Abstract available
    
    
27. LIU M, Huang M, Shui Y, Biville F, et al
    Roles of B739_1343 in iron acquisition and pathogenesis in Riemerella anatipestifer CH-1 and evaluation of the RA-CH-1DeltaB739_1343 mutant as an attenuated vaccine.
    PLoS One. 2018;13:e0197310.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

28. MWANZA-LISULO M, Chomba MS, Chama M, Besa EC, et al
    Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30599.
    PubMed     Text format     Abstract available
    
    
29. ASTILL J, Alkie T, Yitbarek A, Abdelaziz KTA, et al
    Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Vaccine. 2018 May 28. pii: S0264-410X(18)30759.
    PubMed     Text format     Abstract available
    
    
30. LIU X, Yang C, Zhong Q, Song Q, et al
    Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011-2016.
    Vaccine. 2018 May 26. pii: S0264-410X(18)30751.
    PubMed     Text format     Abstract available
    
    
31. LIU H, de Almeida RS, Gil P, Majo N, et al
    Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Vaccine. 2018 May 26. pii: S0264-410X(18)30738.
    PubMed     Text format     Abstract available
    
    
32. CHATTOPADHYAY A, Aguilar PV, Bopp NE, Yarovinsky TO, et al
    A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30761.
    PubMed     Text format     Abstract available
    
    
33. ALEXANDER KE, Tong PL, Macartney K, Beresford R, et al
    Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30744.
    PubMed     Text format     Abstract available
    
    
34. BURGER EA, Campos NG, Sy S, Regan C, et al
    Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30558.
    PubMed     Text format     Abstract available
    
    
35. MARTORELLI L, Garimano N, Fiorentino GA, Vilte DA, et al
    Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30679.
    PubMed     Text format     Abstract available
    
    
36. HENNINGER ML, Kuntz JL, Firemark AJ, Varga AM, et al
    Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination.
    Vaccine. 2018 May 24. pii: S0264-410X(18)30713.
    PubMed     Text format     Abstract available
    
    
37. MARKOWITZ LE, Drolet M, Perez N, Jit M, et al
    Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30117.
    PubMed     Text format     Abstract available
    
    
38. WANG LJ, Xiao T, Xu C, Li J, et al
    Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30715.
    PubMed     Text format     Abstract available
    
    
39. BOYD ED, Phillips JM, Schoenberger YM, Simpson T, et al
    Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30605.
    PubMed     Text format     Abstract available
    
    
40. KOUL PA, Mir H
    The biggest barrier to influenza vaccination in pregnant females in India: Poor sensitization of the care providers.
    Vaccine. 2018;36:3569-3570.
    PubMed     Text format    
    
    
41. MPABALWANI EM, Simwaka JC, Mwenda JM, Matapo B, et al
    Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30274.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: